This inventor holds 2 USPTO granted patents. Top assignee: Yamanouchi Pharmaceutical Company Ltd.. Active years: 1987-1988.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1987-1988
Title: Seiya Kagatani: Innovator in Pharmaceutical Compositions
Introduction
Seiya Kagatani is a notable inventor based in Shizuoka, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compositions for nasal administration.
Latest Patents
Kagatani holds 2 patents that focus on pharmaceutical compositions comprising calcitonin. His latest patents include formulations designed for intranasal administration, which incorporate various absorption enhancers. These enhancers are selected from a group that includes benzyl alcohol, ethanol, thiamine, salicylic acid, capric acid, Macrogol 400, pyridoxal, malic acid, and pyrophosphoric acid, all suitable for application to the nasal mucosa.
Career Highlights
Kagatani is currently associated with Yamanouchi Pharmaceutical Company Ltd., where he continues to innovate in the pharmaceutical sector. His work emphasizes the importance of effective drug delivery systems, particularly for nasal applications.
Collaborations
Throughout his career, Kagatani has collaborated with esteemed colleagues such as Shunji Hasumi and Takashi Sonobe. These partnerships have contributed to the advancement of his research and the successful development of his patented compositions.
Conclusion
Seiya Kagatani's contributions to pharmaceutical innovations highlight his expertise in creating effective nasal drug delivery systems. His work continues to impact the field positively, showcasing the importance of collaboration and innovation in pharmaceutical research.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile